Doravirine
ATC J05AG06 · 12 markets · 23 records
US 4 records · 3 shown of 3
Only this ingredient
- 100 mgtabletPIFELTRO
CA 3 records · 3 shown of 3
Only this ingredient
- 100 mgtabletPIFELTRO
GB 2 records · 2 shown of 2
Only this ingredient
- 100 mgtabletPIFELTRO
Combination products containing this ingredient
- 100 mgtablet CombinationDoravirine 100 mg + Lamivudine 300 mg + Tenofovir Disoproxil 245 mgDELSTRIGO
TW 2 records · 0 shown of 0
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
HK 2 records · 0 shown of 0
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 2 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 2 records · 2 shown of 2
Only this ingredient
- 100 mgtabletPIFELTRO 100 mg, comprimé pelliculé
Combination products containing this ingredient
- 100 mgtablet CombinationDoravirine 100 mg + Lamivudine 300 mg + Tenofovir 300 mgDELSTRIGO 100 mg/300 mg/245 mg, comprimé pelliculé
AU 1 records · 1 shown of 1
Only this ingredient
- 100 mgtabletPIFELTRO doravirine 100 mg film-coated tablet bottle
SG 1 records · 1 shown of 1
Only this ingredient
- 100 mgtabletPIFELTRO
CN 1 records · 1 shown of 1
Only this ingredient
- 100 mgtablet沛卓多拉韦林
ES 1 records · 1 shown of 1
Only this ingredient
- 100 mgtabletPIFELTRO
| Strength / form / release | US | GB | CA | AU | SG | CN | ES | TW | HK | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 100 mg tablet | PIFELTRO | PIFELTRO | PIFELTRO | PIFELTRO doravirine 100 mg film-coated tablet bottle | PIFELTRO | 沛卓多拉韦林 | PIFELTRO | PIFELTRO 100 mg, comprimé pelliculé | |||
| 100 mg Combination Doravirine 100 mg + Islatravir 0.25 mg tablet | IDVYNSO | IDVYNSO | |||||||||
| 100 mg Combination Doravirine 100 mg + Lamivudine 300 mg + Tenofovir Disoproxil 300 mg tablet | DELSTRIGO | DELSTRIGO | |||||||||
| 100 mg Combination Doravirine 100 mg + Lamivudine 300 mg + Tenofovir Disoproxil 245 mg tablet | DELSTRIGO | ||||||||||
| 100 mg Combination Doravirine 100 mg + Lamivudine 300 mg + Tenofovir 300 mg tablet | DELSTRIGO 100 mg/300 mg/245 mg, comprimé pelliculé | ||||||||||
tablet | PIFELTRO 平菲妥膜衣錠 | ||||||||||
unknown | PIFELTRO | PIFELTRO | |||||||||
| Combination Doravirine + Lamivudine + Tenofovir Disoproxil tablet | DELSTRIGO 達滋克膜衣錠 | ||||||||||
| Combination Doravirine + Lamivudine + Tenofovir Disoproxil Fumarate unknown | DELSTRIGO | ||||||||||
| Combination Doravirine + Lamivudine + Tenofovir Disoproxil unknown | DELSTRIGO |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
5 more strength/form rows are recorded only in GB · HK · EU · FR and are not shown in this table. Hay 5 filas de concentración/forma registradas solo en GB · HK · EU · FR que no se muestran en esta tabla. 另有 5 个规格/剂型仅在 GB · HK · EU · FR 有记录(未在本表显示)。 另有 5 個規格/劑型僅在 GB · HK · EU · FR 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.